Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | XDH | P47989 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5220625 | 0.96 | CA12 (0.46) | CA1CA2CA12CA7CA9 | |
| SCHEMBL24017413 | 0.94 | CA12 (0.41) | CA1CA2CA12CA7CA9 | |
| SCHEMBL5217371 | 0.90 | KDM4E (0.41) | CA1CA2CA12CA7CA9 | |
| SCHEMBL3554199 | 0.89 | CA1 (0.42) | CA1CA2CA12CA7CA9 | |
| SCHEMBL5574255 | 0.83 | CA1 (0.43) | CA1CA2CA12CA7CA9 | |
| SCHEMBL26702131 | 0.83 | ALDH1A1 (0.37) | CA1CA2CA12CA7CA9 | |
| SCHEMBL24372708 | 0.82 | ALDH1A1 (0.49) | GAAALDH1A1TSHRRAB9A | |
| SCHEMBL11312872 | 0.82 | CA1 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL5574878 | 0.82 | CYP1A2 (0.45) | KDM4ELMNAL3MBTL1GAAALDH1A1 | |
| SCHEMBL5574874 | 0.80 | CYP1A2 (0.43) | KDM4ELMNAL3MBTL1GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348432-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-02 | — | — | US | disclosed |
| US-20230348432-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-02 | — | — | US | disclosed |
| CN-115996639-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2023-04-21 | — | — | CN | disclosed |
| US-20220153783-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | FUSION BIOTECHNOLOGY CO., LTD. (KR) | 2022-05-19 | — | — | US | disclosed |
| EP-3925961-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | Fusion Biotechnology Co., Ltd. (KR) | 2021-12-22 | — | — | EP | disclosed |
| WO-2021224323-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-11-11 | — | — | WO | disclosed |
| WO-2021085906-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | 주식회사 퓨전바이오텍 | 2021-05-06 | — | — | WO | disclosed |
| US-20070172600-A1 | Molecular bonding method and molecular bonding device | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATION TECHNOLOGY INCORPORATED (JP) | 2007-07-26 | — | — | US | disclosed |
| US-20070172600-A1 | Molecular bonding method and molecular bonding device | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATION TECHNOLOGY INCORPORATED (JP) | 2007-07-26 | — | — | US | disclosed |
| US-20070172600-A1 | Molecular bonding method and molecular bonding device | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATION TECHNOLOGY INCORPORATED (JP) | 2007-07-26 | — | — | US | disclosed |
| US-20070114400-A1 | Probe | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, INCORPORATED (JP) | 2007-05-24 | — | — | US | disclosed |
| US-20070114400-A1 | Probe | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, INCORPORATED (JP) | 2007-05-24 | — | — | US | disclosed |
| US-7205428-B2 | Thioether derivatives, their method for production and use | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, INCORPORATED ADMINISTRATIVE AGENCY (JP) | 2007-04-17 | — | — | US | disclosed |
| EP-1623953-A1 | PROBE | National Institute of Information and Communications Technology (JP) | 2006-02-08 | — | — | EP | disclosed |
| EP-1621517-A1 | METHOD OF BONDING MOLECULE AND MOLECULE BONDING APPARATUS | National Institute of Information and Communications Technology (JP) | 2006-02-01 | — | — | EP | disclosed |
| EP-1219667-B1 | Novel thioether derivatives, their method for production and use | COMM RES LAB INDEPENDENT ADMIN (JP) | 2004-08-04 | — | — | EP | disclosed |
| US-6630578-B2 | Which respond immediately by emission of light when stimulated with light or electric energy, and are useful as switching material of memory | COMMUNICATIONS RESEARCH LABORATORY, INDEPENDENT ADMINISTRATIVE INSTITUTION (JP) | 2003-10-07 | — | — | US | disclosed |
| US-20030171507-A1 | Novel thioether derivatives, their method for production and use | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, INCORPORATED ADMINISTRATIVE AGENCY (JP) | 2003-09-11 | — | — | US | disclosed |
| EP-1219667-A2 | Novel thioether derivatives, their method for production and use | Communications Research Laboratory, Independent Administrative Institution (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-20020072583-A1 | Novel thioether derivatives, their method for production and use | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, INCORPORATED ADMINISTRATIVE AGENCY (JP) | 2002-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348432-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | CYP4F3, CYP4X1, GLRX3 | CA1 4440/4885CA2 3769/4885CA12 4860/4885 |
| US-20220153783-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | TFAM, HSPA9, AIFM1 | CA1 4542/4885CA2 2758/4885CA12 4746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.